Ractigen Therapeutics Reports First-In-Human RNA Activation Data
Shanghai, China, September 16, 2026 Ractigen Therapeutics has announced that it will present first-in-human clinical data from its RNA...
cancer detection
Advertisement
Lumicell Expands LumiSystem Use in Breast Cancer Surgery Now
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
Leap Therapeutics Reports DKK1 Findings in CRC Study Results
Cambridge, Massachusetts, August 12, 2026 Leap Therapeutics has announced the publication of final results from its randomized Phase 2...
Function and NYU Partner on Early Disease Detection Research
Austin, Texas, August 12, 2026 Function Health has announced a research partnership with NYU Grossman School of Medicine to...
Johnson & Johnson’s RYBREVANT FASPRO Shows Strong HNSCC Results
CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...
Advertisements
GRAIL’s Galleri® Test Increases Cancer Detection 6.5-Fold in PATHFINDER 2 Study
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
DELFI Diagnostics Expands Blood-Based Lung Screening
PALO ALTO, Calif., May 13, 2026 DELFI Diagnostics announced that it will present the first-ever clinical utility data for...
Ribo and Boehringer Advance siRNA MASH Program
SUZHOU, China, May 6, 2026 Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB announced the achievement of...
HelioLiver Blood Test Shows Strong HCC Detection
IRVINE, Calif., May 6, 2026 Helio Genomics announced publication of landmark clinical data demonstrating that its HelioLiver™ multi-analyte blood...
UK Approves Avantect Multi-Cancer and Ovarian Tests
SAN DIEGO, Sept. 25, 2025 — ClearNote Health announced that it has received UK Conformity Assessed (UKCA) approval for...
Advertisement
